Merck Sharp Dome News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Merck Sharp Dome. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Merck Sharp Dome Today - Breaking & Trending Today

ASCO 2024: Belzutifan in Patients with Advanced Clear Cell Renal Cell Carcinoma: Subgroup Analysis of the Phase 2 LITESPARK-013 Study

Published: June 2, 2024

ASCO 2024, advanced clear cell renal cell carcinoma (ccRCC), Belzutifan, LITESPARK-013 Study, vascular endothelial growth factor (VEGF) tyrosine kinase inhibitor (TKI).

Source: urotoday.com

Related Topics:

United StatesGeorgetown UniversityDistrict Of ColumbiaMichael AtkinsMichaelb AtkinsUniversity Of TorontoGeorgetown Lombardi Comprehensive Cancer CenterDepartment Of Medical OncologyDatabase ConsortiumGeorgetown University Medical CenterMerck Sharp DomeSociety Of Urologic OncologyInternational MetastaticAmerican Society Of Clinical OncologyClinical OncologyAnnual MeetingDeputy DirectorScholl ProfessorVice ChairMedical OncologyRashid SayyidUrologic OncologyClinical Fellow